eXoZymes, Inc. (EXOZ)
4.30
+0.19
(+4.62%)
USD |
NASDAQ |
Nov 06, 10:10
eXoZymes Market Cap : 39.91M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 38.15M |
| November 04, 2026 | 40.00M |
| November 03, 2026 | 44.09M |
| November 02, 2026 | 41.95M |
| October 30, 2026 | 38.33M |
| October 29, 2026 | 38.15M |
| October 28, 2026 | 39.21M |
| October 27, 2026 | 35.27M |
| October 26, 2026 | 34.81M |
| October 23, 2026 | 37.13M |
| October 22, 2026 | 36.20M |
| October 21, 2026 | 36.38M |
| October 20, 2026 | 38.24M |
| October 19, 2026 | 37.13M |
| October 16, 2026 | 37.96M |
| October 15, 2026 | 37.13M |
| October 14, 2026 | 42.69M |
| October 13, 2026 | 42.60M |
| October 12, 2026 | 46.87M |
| October 09, 2026 | 48.73M |
| October 08, 2026 | 48.91M |
| October 07, 2026 | 51.42M |
| October 06, 2026 | 51.23M |
| October 05, 2026 | 51.23M |
| October 02, 2026 | 53.55M |
| Date | Value |
|---|---|
| October 01, 2026 | 53.46M |
| September 30, 2026 | 54.11M |
| September 29, 2026 | 56.62M |
| September 28, 2026 | 55.69M |
| September 25, 2026 | 57.96M |
| September 24, 2026 | 58.80M |
| September 23, 2026 | 59.22M |
| September 22, 2026 | 57.45M |
| September 21, 2026 | 56.99M |
| September 18, 2026 | 59.73M |
| September 17, 2026 | 57.45M |
| September 16, 2026 | 57.17M |
| September 15, 2026 | 61.03M |
| September 14, 2026 | 58.29M |
| September 11, 2026 | 58.49M |
| September 10, 2026 | 57.27M |
| September 09, 2026 | 57.27M |
| September 08, 2026 | 58.57M |
| September 04, 2026 | 63.58M |
| September 03, 2026 | 63.11M |
| September 02, 2026 | 63.02M |
| September 01, 2026 | 60.33M |
| August 31, 2026 | 62.46M |
| August 28, 2026 | 66.53M |
| August 27, 2026 | 66.59M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 224.83M |
| Perspective Therapeutics, Inc. | 99.73M |
| MiMedx Group, Inc. | 487.39M |
| ABVC BioPharma, Inc. | 24.64M |
| Endonovo Therapeutics, Inc. | 0.1808M |
Market Cap Related Metrics
| PEG Ratio | -0.1653 |
| Price to Book Value | 10.92 |
| Price | 4.30 |
| Earnings Yield | -27.95% |
| PEGY Ratio | -0.1653 |